197 related articles for article (PubMed ID: 26785905)
1. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(3):289-306. PubMed ID: 26785905
[TBL] [Abstract][Full Text] [Related]
2. Interactions between DNA and gemini surfactant: impact on gene therapy: part II.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(4):403-20. PubMed ID: 26784450
[TBL] [Abstract][Full Text] [Related]
3. The influence of novel gemini surfactants containing cycloalkyl side-chains on the structural phases of DNA in solution.
Pietralik Z; Kumita JR; Dobson CM; Kozak M
Colloids Surf B Biointerfaces; 2015 Jul; 131():83-92. PubMed ID: 25969417
[TBL] [Abstract][Full Text] [Related]
4. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
[TBL] [Abstract][Full Text] [Related]
5. New serine-derived gemini surfactants as gene delivery systems.
Cardoso AM; Morais CM; Cruz AR; Silva SG; do Vale ML; Marques EF; de Lima MC; Jurado AS
Eur J Pharm Biopharm; 2015 Jan; 89():347-56. PubMed ID: 25513958
[TBL] [Abstract][Full Text] [Related]
6. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
7. Modulation of pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on lipoplex transfection properties.
Sharma VD; Lees J; Hoffman NE; Brailoiu E; Madesh M; Wunder SL; Ilies MA
Mol Pharm; 2014 Feb; 11(2):545-59. PubMed ID: 24377350
[TBL] [Abstract][Full Text] [Related]
8. Bis-quaternary gemini surfactants as components of nonviral gene delivery systems: a comprehensive study from physicochemical properties to membrane interactions.
Cardoso AM; Morais CM; Silva SG; Marques EF; de Lima MC; Jurado MA
Int J Pharm; 2014 Oct; 474(1-2):57-69. PubMed ID: 25111434
[TBL] [Abstract][Full Text] [Related]
9. Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Chitanda J; Al-Dulaymi M; Verrall R; Badea I
Pharm Res; 2017 Sep; 34(9):1886-1896. PubMed ID: 28643235
[TBL] [Abstract][Full Text] [Related]
10. Compaction of DNA by gemini surfactants: effects of surfactant architecture.
Karlsson L; van Eijk MC; Söderman O
J Colloid Interface Sci; 2002 Aug; 252(2):290-6. PubMed ID: 16290792
[TBL] [Abstract][Full Text] [Related]
11. Structural, biocomplexation and gene delivery properties of hydroxyethylated gemini surfactants with varied spacer length.
Zakharova LY; Gabdrakhmanov DR; Ibragimova AR; Vasilieva EA; Nizameev IR; Kadirov MK; Ermakova EA; Gogoleva NE; Faizullin DA; Pokrovsky AG; Korobeynikov VA; Cheresiz SV; Zuev YF
Colloids Surf B Biointerfaces; 2016 Apr; 140():269-277. PubMed ID: 26764110
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and aggregation properties of dissymmetric phytanyl-gemini surfactants for use as improved DNA transfection vectors.
Wang H; Wettig SD
Phys Chem Chem Phys; 2011 Jan; 13(2):637-42. PubMed ID: 20981388
[TBL] [Abstract][Full Text] [Related]
13. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
Wettig SD; Badea I; Donkuru M; Verrall RE; Foldvari M
J Gene Med; 2007 Aug; 9(8):649-58. PubMed ID: 17654656
[TBL] [Abstract][Full Text] [Related]
14. Mixed aggregate formation in gemini surfactant/1,2-dialkyl-sn-glycero-3-phosphoethanolamine systems.
Akbar J; Tavakoli N; Marangoni DG; Wettig SD
J Colloid Interface Sci; 2012 Jul; 377(1):237-43. PubMed ID: 22515995
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
[TBL] [Abstract][Full Text] [Related]
16. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency.
Cardoso AM; Faneca H; Almeida JA; Pais AA; Marques EF; de Lima MC; Jurado AS
Biochim Biophys Acta; 2011 Jan; 1808(1):341-51. PubMed ID: 20937247
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and use of asymmetric pyrenyl-gemini surfactants as emissive components in DNA-lipoplex systems.
Wang C; Wettig SD; Foldvari M; Verrall RE
Langmuir; 2007 Aug; 23(17):8995-9001. PubMed ID: 17637001
[TBL] [Abstract][Full Text] [Related]
18. Lipoplexes formed from sugar-based gemini surfactants undergo a lamellar-to-micellar phase transition at acidic pH. Evidence for a non-inverted membrane-destabilizing hexagonal phase of lipoplexes.
Wasungu L; Stuart MC; Scarzello M; Engberts JB; Hoekstra D
Biochim Biophys Acta; 2006 Oct; 1758(10):1677-84. PubMed ID: 16930530
[TBL] [Abstract][Full Text] [Related]
19. Physical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings.
Sum CH; Nafissi N; Slavcev RA; Wettig S
PLoS One; 2015; 10(11):e0142875. PubMed ID: 26561857
[TBL] [Abstract][Full Text] [Related]
20. Peptide-Modified Gemini Surfactants: Preparation and Characterization for Gene Delivery.
Al-Dulaymi M; Mohammed-Saeid W; El-Aneed A; Badea I
Methods Mol Biol; 2019; 2000():203-225. PubMed ID: 31148017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
